SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-16-003463
Filing Date
2016-05-11
Accepted
2016-05-11 17:04:04
Documents
4
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v439243_10q.htm 10-Q 768979
2 EXHIBIT 31.1 v439243_ex31-1.htm EX-31.1 7066
3 EXHIBIT 31.2 v439243_ex31-2.htm EX-31.2 7251
4 EXHIBIT 32.1 v439243_ex32-1.htm EX-32.1 6304
  Complete submission text file 0001279569-16-003463.txt   790557
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37426 | Film No.: 161640633
SIC: 2834 Pharmaceutical Preparations